Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction
George E Fragoulis,1,* Stergios Soulaidopoulos,2,* Petros P Sfikakis,1 Theodoros Dimitroulas,3 George D Kitas4,5 1Rheumatology Unit, Joint Rheumatology Program, Medical School, First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, “Laiko&rd...
Saved in:
Main Authors: | Fragoulis GE (Author), Soulaidopoulos S (Author), Sfikakis PP (Author), Dimitroulas T (Author), Kitas GD (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monitoring and Managing Cardiovascular Risk in Immune Mediated Inflammatory Diseases
by: Anyfanti P, et al.
Published: (2021) -
Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation
by: Zhao Gao, et al.
Published: (2021) -
Metabolic Memory in Diabetes - Mechanistic Insights and the Impact of Cardiovascular Medication
by: Raluca SOSDEAN, et al.
Published: (2021) -
Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study
by: Theodoros Dimitroulas, et al.
Published: (2015) -
Mechanistic insights on anticancer drugs with specific biological targets and signalling pathways
by: Mohsina Patwekar, et al.
Published: (2023)